Posters

Enhancement of rAAV2 Viral Vector Yield Recovery in Upstream Lysate Material

Pharmaron’s innovative adeno-associated virus (AAV) high-throughput process platform approach provides rapid access to increased titres and higher recoveries. AAV serotypes…
Posters

Utilising HTPD and DoE to Optimise the Pharmaron Gene Therapy Platform

At Pharmaron, we have successfully developed a platform process for the creation of AAV gene therapies with a highly adaptive…
Posters

14C-Radiolabelled Human AME: A Review of Clinical Mass Balance Rates and Routes of Elimination

It has been over 13 years since the initial FDA MIST guidance (2008) came out outlining the importance of evaluating…
Posters

Optimization of Method for Measuring AGP-mediated Protein Binding in Dog Plasma

It is well described that due to a polymorphism in the dog the expression of acid-1-glycoprotein (AGP) can be variable,…
Posters

Innovative Separation Sciences for Accurate Plasmid Analysis

Pharmaron’s innovative adeno-associated virus (AAV) process and analytical platform approach provides cell banks, plasmids and AAV manufacturing to our customers….